Abstract
Post-transplant lymphoproliferative disorder (PTLD) is a frequent and often fatal complication of organ transplantation. It most often results from an Epstein-Barr virus (EBV)-transformed B-cell clone, which expresses B-cell surface markers such as CD20. We describe a case of a heart transplant recipient who EBV seroconverted post-transplant and subsequently developed subcutaneous and lymphatic B-cell lymphoma, successfully treated with CD20 antibody (rituximab). The patient has been in remission during 10 months of clinical follow-up.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 770-772 |
| Number of pages | 3 |
| Journal | Journal of Heart and Lung Transplantation |
| Volume | 20 |
| Issue number | 7 |
| DOIs | |
| State | Published - 2001 |
| Externally published | Yes |
Bibliographical note
Copyright:Copyright 2007 Elsevier B.V., All rights reserved.
